Differences

This shows you the differences between two versions of the page.

--- public_health_agencies:canada:lynora_saxinger [2022/01/08 20:53]
liam [Public Health Agency of Canada]
+++ — (current)
@@ Line 1: / Line 1: @@
-====== Lynora Saxinger ======
-{{ :public_health_agencies:canada:lynora-saxinger.png?250|}}
-Dr. **Lynora Saxinger**, CTropMed, MD, FRCPC, is an academic infectious diseases specialist, whose professional career outside patient care is focused on antimicrobial stewardship and antimicrobial resistance, with involvement in hospital, health system and national collaborations to improve antibiotic stewardship practice, and resistance and utilization surveillance.((//Faculty of Medicine & Dentistry.// DR. LYNORA SAXINGER. University of Alberta. Retrieved January 8, 2022, from https://archive.ph/Hm7d4))
-===== Education =====
-Saxinger completed her Bachelor of Science at the [[:University of Saskatachewan]] in 1992, then her MD in 1996. She became a Fellow of the [[:Royal College of Physicians and Surgeons of Canada]] in 2000.
-===== Affiliations =====
-==== Alberta Health Services ====
-Saxinger is Co-Chair of COVID-19 Scientific Advisory Group under [[Alberta Health Services]] alongside [[Braden Manns]], advising Alberta's [[:COVID-19]] [[:public health]] response.((//2019-nCoV Scientific Advisory Group.// (2021, May 27). Alberta Health Services. https://www.albertahealthservices.ca/assets/info/ppih/if-ppih-covid-19-sag-terms-of-reference.pdf)) She is also tasked with "engagement in social media and media based scientific communication and knowledge translation for public education around COVID-19."((//Final Program - 2021 Annual Conference.// AMMI. Retrieved January 8, 2022, from https://www.ammi.ca/Content/2021%20Final%20Program_FINAL.pdf))
-=== Suppression of Ivermectin ===
-In this role, Saxinger co-authored an article insisting that [[:Ivermectin]] not be used to treat COVID-19. She and her colleagues falsely claimed that "there is no evidence that ivermectin benefits COVID-19 patients, but there are known harms. Ivermectin use has been associated with rash, nausea, vomiting, low blood pressure, abdominal pain, tremors, seizures and severe hepatitis (liver disease) requiring hospitalization." The conclusion they reach is "Vaccination remains our best means of preventing COVID-19. Our [[:vaccines]] are safe, fully approved and have been studied in high quality trials of tens of thousands of people."((Manns, B., Saxinger, L., & Joffe, M. (2021, October 12). //Alberta Health Services: Ivermectin is a useful drug, but not a treatment for COVID-19.// MSN News; Calgary Herald. https://archive.ph/11Xqr))
-The comments left by readers overwhelmingly objected to the authors' statements and accused them of negligence, supporting their criticism with references to the [[:British Ivermectin Recommendation Development]] (BIRD) Group, [[:Pierre Kory]] and [[:Sanjay Gupta]]'s heated exchange with [[:Joe Rogan]] after [[:CNN]] levelled the same propagandistic claims at him.((Heine, D. (2021, October 14). //Joe Rogan Confronts CNN’s Dr. Sanjay Gupta on Network’s COVID Lies.// American Greatness. https://archive.ph/mKmiP)) ((Manns, B., Saxinger, L., & Joffe, M. (2021b, October 12). //Alberta Health Services: Ivermectin is a useful drug, but not a treatment for COVID-19.// Calgary Herald; Postmedia Network Inc. https://calgaryherald.com/opinion/columnists/alberta-health-services-ivermectin-is-a-useful-drug-but-not-a-treatment-for-covid-19))
-Members of the public have described Saxinger as "corrupt". Dr. [[:William Makis]] called for an investigation into why she and her colleagues blocked Ivermectin.((@MakisMD. (2021, June 15). //We first need a full Investigation of the AHS COVID-19 Scientific Advisory Group lead by NDP/AHS Executive Braden Manns and his associates like  @AntibioticDoc  and  @drslmd.// Twitter. https://archive.ph/lFAhb))
-=== Censorship of Opposing Voices ===
-In disturbing irony, Saxinger opined that "more academics and people in medicine should consider what they can contribute to public discussions. If you can step in, it really is an asset to be able to do it. And it might take a bit of practice before you're comfortable, but it really demonstrates and applies our skills in a public way."((Bauer, K. (2020, September 16). //Pandemic Perspectives: Lynora Saxinger.// University of Alberta. https://archive.ph/qHWYd))
-This is perhaps an example of [[:gaslighting]], or an indication that she was ignorant to the widespread [[:censorship]] of opposing medical voices taking place across Canada and the world during the [[COVID-19 pandemic]].
-==== Association of Medical Microbiology and Infectious Diseases Canada ====
-Saxinger is a founding member and past chair of the Antimicrobial Resistance and Stewardship Committee of the [[:Association of Medical Microbiology and Infectious Diseases Canada]].((//Faculty of Medicine & Dentistry.// DR. LYNORA SAXINGER. University of Alberta. Retrieved January 8, 2022, from https://archive.ph/Hm7d4)) She was a speaker at AMMI's 2021 Annual Conference, for a presentation titled "Strategic Deployment of COVID-19 Treatment Options: Who, What, Where and How?".((//Final Program - 2021 Annual Conference.// AMMI. Retrieved January 8, 2022, from https://www.ammi.ca/Content/2021%20Final%20Program_FINAL.pdf))
-AMMIDC is partnered with the [[:Canadian College of Microbiologists]] (CCM), the [[:Canadian Foundation for Infectious Diseases]] (CFID), the [[:Canadian Medical Association]], [[:Choosing Wisely Canada]], the [[:European Society of Clinical Microbiology and Infectious Diseases]] (ESCMID), the [[:International Society of Antimicrobial Chemotherapy]], and the [[:Pan American Society for Clinical Virology]] (PASCV).((//Partnerships.// Association of Medical Microbiology and Infectious Disease Canada. Retrieved January 8, 2022, from https://archive.ph/Uzsmx))
-The organization receives sponsorship funds from [[:pharmaceutical_companies:Merck]], [[:pharmaceutical_companies:Gilead Sciences]], [[:pharmaceutical_companies:Seqirus]], [[:DiaSorin]], [[:Hologic]], [[:pharmaceutical_companies:Roche]], [[:pharmaceutical_companies:Pfizer]], [[:pharmaceutical_companies:Avir Pharma]], [[:pharmaceutical_companies:Moderna]], and [[:R-Biopharm AG]].((//Sponsorship & Exhibitor Prospectus.// (2021, December). Association of Medical Microbiology and Infectious Diseases Canada. https://ammi.ca/wp-content/uploads/2021/12/2022-Sponsorship-.Exhibitor-ProspectusFINAL.pdf)) ((//2021 Annual Conference.// AMMI. Retrieved January 8, 2022, from https://archive.ph/PLAHX))
-==== National Collaborating Centre for Infectious Diseases ====
-Saxinger is a partner at the [[:National Collaborating Centre for Infectious Diseases]] (NCCID) where she was a Principle Investigator of a commissioned 2012 report titled "Antimicrobial Resistance and Utilization Surveillance in Canada".((//Lynora Saxinger.// (2015, March 30). National Collaborating Centre for Infectious Diseases. https://archive.ph/TKd0U))
-==== Public Health Agency of Canada ====
-Saxinger has worked as an advisor with the Canadian Hospital Epidemiology Committee/Canadian Nosocomial Infection Surveillance Program (CNISP) collaboration with the [[Public Health Agency of Canada]], as well as with the Canadian Integrated Program for Antimicrobial Resistance in utilization reporting of human antimicrobial use data.((Haworth-Brockman, M., Saxinger, L. M., Miazga-Rodriguez, M., Wierzbowski, A., & Otto, S. J. G. (2021). //One Health Evaluation of Antimicrobial Use and Resistance Surveillance: A Novel Tool for Evaluating Integrated, One Health Antimicrobial Resistance and Antimicrobial Use Surveillance Programs.// Frontiers in Public Health, 9. https://doi.org/10.3389/fpubh.2021.693703))
-==== University of Alberta ====
-Saxinger is an Associate Professor in the Department of Medicine, Division of Infectious Diseases at the [[:University of Alberta]].((//Faculty of Medicine & Dentistry.// DR. LYNORA SAXINGER. University of Alberta. Retrieved January 8, 2022, from https://archive.ph/Hm7d4))